GlassScriptPhysician profile
Lauren Bailey Small
NPI 1194284117
$1,334.83
in general payments reported to CMS, 2019-2025
16 companies · $608 in 2025
The $608 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.02 · 2022: $62.16 · 2023: $510 · 2024: $143 · 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $955 · Travel and Lodging: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $955.49 |
| Travel and Lodging | $306.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $704.11 | 2023-2025 | Xeomin |
| Novo Nordisk INC | $155.01 | 2023-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $97.50 | 2023-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Lilly USA, LLC | $76.10 | 2022-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $61.95 | 2023-2025 | |
| Amgen INC. | $40.90 | 2024 | Repatha, Otezla |
| Abbott Laboratories | $40.27 | 2024-2025 | Freestyle Libre 3 |
| Abbvie INC. | $31.09 | 2024 | |
| Supernus Pharmaceuticals, INC. | $22.73 | 2025 | Qelbree |
| Daiichi Sankyo INC. | $22.02 | 2025 | Injectafer |
| Sumitomo Pharma America, INC. | $20.71 | 2025 | Gemtesa |
| Mylan Specialty L.P. | $14.48 | 2023 | Yupelri |
| Novartis Pharmaceuticals Corporation | $14.25 | 2025 | |
| Exact Sciences Corporation | $13.61 | 2023 | Cologuard Collection Kit |
| Genentech USA, INC. | $11.02 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynavax Technologies Corporation | $9.08 | 2024 | Heplisav-B |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Small listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.